垂体神经内分泌肿瘤中抑癌基因DNA甲基化研究
该研究采用甲基化特异性多重连接依赖探针扩增和定量实时PCR技术,分析105例垂体神经内分泌肿瘤中35个抑癌基因的启动子高甲基化与基因表达,发现不同亚型甲基化模式各异,TP73甲基化与表达负相关,MSH6和CADM1在大腺瘤中甲基化频率更高,ESR1和RASSF1在非侵袭性肿瘤中甲基化更高。
要点
- 不同PitNET亚型间抑癌基因甲基化模式存在差异
- TP73甲基化与基因表达呈负相关(P=0.013)
- MSH6和CADM1在大腺瘤中甲基化频率高于微腺瘤
核心结论
- 抑癌基因DNA甲基化选择性影响其基因表达及PitNET的生长和侵袭性。
- PitNET各亚型应被视为不同实体,因功能性与静默性肿瘤在大小分布上存在偏倚。
研究设计与样本
- 采用甲基化特异性多重连接依赖探针扩增和定量实时PCR技术,分析105例PitNET中35个抑癌基因的DNA启动子高甲基化和基因表达。
- 根据临床表现定义肿瘤功能性,根据Hardy分类定义大小,根据MRI海绵窦侵袭定义侵袭性。
主要发现
- TP73甲基化状态与基因表达在总体系列中呈负相关(P=0.013),并在部分亚型中亦呈负相关。
- MSH6和CADM1在总体系列和 corticotroph PitNET 中,大腺瘤的甲基化频率高于微腺瘤(所有P≤0.053)。
- ESR1和RASSF1在总体系列中非侵袭性肿瘤的甲基化程度高于侵袭性肿瘤(P分别为0.054和0.031),在 gonadotroph 亚型中亦如此(P分别为0.055和0.050)。
- ESR1和CASP8在功能性 corticotroph 肿瘤中高甲基化程度高于静默性肿瘤(P均为0.034)。
关键数值与推荐
- TP73甲基化与基因表达负相关,总体系列P=0.013。
- MSH6和CADM1在大腺瘤vs微腺瘤甲基化频率比较,总体及corticotroph亚型所有P≤0.053。
- ESR1和RASSF1在非侵袭性vs侵袭性肿瘤甲基化比较,总体P=0.054和P=0.031,gonadotroph亚型P=0.055和P=0.050。
- ESR1和CASP8在功能性vs静默性corticotroph肿瘤中甲基化比较,P均为0.034。
临床怎么用
- 抑癌基因甲基化模式可作为区分PitNET亚型及评估肿瘤生长和侵袭行为的潜在分子标志。
- 临床解读甲基化数据时需考虑PitNET亚型差异及肿瘤大小与功能性之间的偏倚。
局限性
- 功能性评估存在偏倚:所有接受手术的静默性肿瘤均为大腺瘤,而所有手术的微腺瘤均为功能性肿瘤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Epigenetic alterations may play a role in the development and behavior of pituitary neuroendocrine tumors (PitNETs). OBJECTIVE: To evaluate the effect of methylation of tumor suppressor genes (TSGs) on their gene expression and on the behavior of PitNETs. MATERIAL AND METHODS: We used methylation-specific multiplex ligation-dependent probe amplification and quantitative real-time PCR techniques to analyze the DNA-promoter hypermethylation and gene expression of 35 TSGs in 105 PitNETs. We defined functionality, size, and invasiveness of tumors according to their clinical manifestations, Hardy's classification, and MRI invasiveness of the cavernous sinus, respectively. RESULTS: We observed different methylation patterns among PitNET subtypes. The methylation status of TP73 correlated negatively with its gene expression in the overall series (P = 0.013) and in some subtypes. MSH6 and CADM1 showed higher methylation frequency in macroadenomas than in microadenomas in the overall series and in corticotroph PitNETs (all P ≤ 0.053). ESR1 and RASSF1 were more highly methylated in noninvasive than in invasive tumors in the overall series (P = 0.054 and P = 0.031, respectively) and in the gonadotroph subtype (P = 0.055 and P = 0.050, respectively). ESR1 and CASP8 appeared more hypermethylated in functioning than in silent corticotroph tumors (P = 0.034 and P = 0.034, respectively). CONCLUSIONS: DNA methylation of TSGs has a selective effect on their gene expression and on the growth and invasiveness of PitNETs. Its involvement in their functionality is biased because all silent operated tumors are macroadenomas, whereas all operated microadenomas are functioning ones. Therefore, the subtypes of PitNETs should be considered different entities.
引用
- García-Martínez A, Sottile J, Sánchez-Tejada L, et al. DNA Methylation of Tumor Suppressor Genes in Pituitary Neuroendocrine Tumors. J Clin Endocrinol Metab. 2019. PMID: 30423170. doi:10.1210/jc.2018-01856
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。